|
|
|
|
||
Newly Appointed Sr. VP, MNKD's Endocrine Business Unit, Matthew Nguyen, PharmD He has been with MNKD since May, 2022. He previously held senior positions with Zealand Pharma, Valeritas Pharma, and was part of the launch team for Lantus and multiple diabetes brands while at Sanofi. It sounds like he had a key role in the commercialization of V-Go. Hope he can also increase Afrezza's role in diabetes. JMHO. Info taken from Mannkind's website. |
return to message board, top of board |